Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acthar in Membranous Nephropathy
NCT03025828Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Mar 2018
- Primary completion
- Dec 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of corticotropin in membranous nephropathy (MN), sponsored by Icahn School of Medicine at Mount Sinai. Started Mar 2018; status: completed.
02
Drugs
corticotropin
03
Conditions
membranous nephropathy (MN)
Beyond the preview
Go deeper on NCT03025828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03025828.